Ehlers-Danlos Related Vascular Disease
Tracking # 20-1350725
$16.00
There are no ratings for this course
What you'll learn
Upon completion of this course, the healthcare professional will be able to:
1. Identify the pathophysiology, genetic basis, and clinical features of vascular Ehlers-Danlos Syndrome.
2. Apply diagnostic and genetic testing methods to confirm vEDS and differentiate it from other connective tissue disorders.
3. Implement evidence-based pharmacologic and surgical strategies to manage vascular risk, prevent complications, and improve patient outcomes
Course overview
Vascular Ehlers Danlos Syndrome (vEDS) is a rare, genetically inherited connective tissue disorder caused by mutations in the COL3A1 gene, resulting in defective type III collagen. It is characterized by fragile blood vessels, risk of arterial rupture, organ fragility, and characteristic facial features. Early recognition is critical due to the life threatening risk of vascular or organ rupture. This course provides healthcare professionals with a detailed review of vEDS, including clinical manifestations, diagnostic strategies, genetic testing, pharmacologic and surgical management, and long-term outcomes.
Subject areas
This course counts toward the state boards and subject areas below.
Arkansas State Board of Nursing
Certified Nurse Midwife
Certified Nurse Practitioner
Certified Registered Nurse Anesthetist
Clinical Nurse Specialist
Licensed Practical Nurse
Licensed Psychiatric Technician Nurse
Registered Nurse
Registered Nurse Practitioner
District of Columbia Board of Nursing
Certified Nurse Midwife
Clinical Nurse Specialist
Licensed Practical Nurse
Nurse Practitioner
Registered Nurse
Registered Nurse Anesthetist
Florida Board of Nursing
APRN Temporary Certificate for Practice in Areas of Critical Need
Advanced Practice Registered Nurse
Licensed Practical Nurse
Registered Nurse
Georgia Board of Nursing
Licensed Practical Nurse
Registered Professional Nurse
New Mexico Board of Nursing
Certified Nurse Practitioner
Certified Registered Nurse Anesthetist
Clinical Nurse Specialist
Licensed Practical Nurse
Registered Nurse
North Dakota Board of Nursing
Advanced Practice Registered Nurse
Licensed Practical Nurse
Registered Nurse
South Carolina Board of Nursing
Advanced Practice Registered Nurse
Licensed Practical Nurse
Registered Nurse
West Virginia Board of Registered Nurses
Advanced Practice Registered Nurse
Registered Nurse
Disclosure statements
Method of Evaluation:
Participant achievement of the stated learning objectives is evaluated through completion of a post-test examination and review of case-based scenarios. A minimum passing score of 70% is required for successful completion.